Respiratory Technology Corporation of Houston, TX at MEDICA 2020 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option

Respiratory Technology Corporation

11011 Brooklet Drive, Suite 300, 77099 Houston, TX
This company is co-exhibitor of
State of Texas


PhD Thomas Ball

VP of Clinical Affairs



Brandon Wang

Director of Business Development - Southeast Asia



Kristen Wedel

Customer Services Manager



Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 01  Electromedical equipment / medical technology
  • 01.01  Diagnostics
  • 01.01.03  Ear, nose and throat diagnostics (ENT)

Ear, nose and throat diagnostics (ENT)

  • 01  Electromedical equipment / medical technology
  • 01.03  Surgery devices, endoscopy devices
  • 01.03.02  Instruments for the minimal-invasive surgery (MIS)

Instruments for the minimal-invasive surgery (MIS)

  • 01  Electromedical equipment / medical technology
  • 01.11  Other equipment for electromedicine / medical technology

Other equipment for electromedicine / medical technology

Our products

Product category: Ear, nose and throat diagnostics (ENT)

Restech Dx-pH Monitoring System

The first and only medical sensor able to monitor real-time, continuous pH in both liquid and aerosolized states, revealing reflux-related etiology of presenting symptoms (e.g. chronic cough, hoarseness, throat clearing, and globus). The sensor is unique in its ability to accurately function anywhere in the aerodigestive tract—from the esophagus to the nasopharynx—reporting precise values of both liquid and aerosol from pH 1–10.

Restech’s in-office reflux test can identify patients overlooked by conventional pH monitoring:
The Dx-pH sensor records the pH of aerosolized material in the oropharynx. Other products lack the proprietary technology to measure aerosolized particulates, consequently missing critical data points and possibly resulting in false negative studies.
The esophageal DeMeester and oropharyngeal RYAN Scores differ in their thresholds. Patients with extraesophageal symptoms can receive a negative esophageal pH study, but when tested by the Dx-pH System, the study could be positive.
The upper airway is more sensitive to enzymes and acids produced in the stomach than the esophagus, meaning that smaller volumes can cause tissue damage and symptoms.

More Less

Product category: Instruments for the minimal-invasive surgery (MIS)

Stretta Therapy for Reflux

When patients suffer from chronic gastroesophageal or laryngopharyngeal reflux disease (GERD or LPRD) that is not well controlled with medications, or where long-term medications are not a viable option, Stretta is an alternative to surgery and implants. Stretta Therapy is a unique non-surgical outpatient procedure, performed transorally, that takes about an hour, with patients returning to normal activities within a few days.

How Stretta Therapy Works

The Stretta system delivers low power, low temperature radiofre­quency (RF) energy to the lower esophageal sphinc­ter (LES) muscle and gastric cardia. This energy remodels the tissue, resulting in improved barrier function and fewer random relaxations that cause reflux symptoms.

Stretta treats the functional problem that may cause GERD: a deficient sphincter muscle.
RF energy has been shown to thicken the musculature and increase the size and amount of smooth muscle fibers in the treatment zone. The result is a measurable strengthening of the LES and a reduction in transient LES relaxations, without stricture or fibrosis. Studies show this effect may repair the deficient sphincter and restore the natural barrier function of the EGJ.

Stretta is by far the most widely studied minimally invasive treatment option for GERD – and has been proven safe and effective in more than 60 clinical studies and 35,000 procedures. Studies show that patients experience significant and lasting symptom relief from 4-15 years, without the higher complication rates of surgery, or the higher costs.

More Less

About us

Company portrait

At Restech, we believe there is a better way to manage reflux. It all started in a meeting with Dr. Tom DeMeester who told our engineers a little secret: the market needs a pH sensor that works outside of the esophagus. Our team accepted the challenge and launched the first real-time sensor that could function highly accurately in a non-liquid environment. Since then, we’ve obsessed over reflux, ensuring we understand the ins and outs of the disease state and industry. Although it is highly complex, we are passionate about bringing simple, effective reflux solutions to patients and clinicians around the world. Our rapid growth reflects our dedication and passion - developing and seeking out new products across the diagnostic and therapeutic continuum.

Company data

Export content max. 50%
Number of employees 20-49
Area of business
  • Imaging and diagnostics / medical equipment & devices
  • Diagnostics